Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06908811 · ClinicalTrials.gov registry record · NA
Effect of a Novel Blend of Plant Protein and Additional Ingredients on Resistance Training Adaptations
A NA study, sponsored by Lindenwood University.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT06908811: Completed NA study, sponsored by Lindenwood University.
NCT06908811 is a NA study that has completed, run by Lindenwood University. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06908811, a NA study, has completed, sponsored by Lindenwood University.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
This study seeks to compare the observed changes in resistance training adaptations (strength, performance, body composition, recovery, and lactate responses) after supplementation of isocaloric and isonitrogenous amounts of a novel plant protein formulation against changes observed in a pea/rice plant protein blend, whey protein, and a carbohydrate placebo in healthy resistance-trained men and women between the ages of 18-39.
Primary Outcome
Lean mass will be assessed using a 4-compartment model, which includes measurements of body density, total body water, and bone mineral content.
Interventions
- DIETARY_SUPPLEMENT Whey Protein
- DIETARY_SUPPLEMENT Novel Plant Protein Blend
- DIETARY_SUPPLEMENT Pea/Rice Protein Blend
- DIETARY_SUPPLEMENT Carbohydrate Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2022-08-19 |
| Est. Completion | 2025-01-17 |
| Phase | NA |
What the finished NCT06908811 record still lists
NCT06908811 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 4 interventions - of which Whey Protein is the first listed.
NCT06908811 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06908811 about?
NCT06908811 is a clinical study titled "Effect of a Novel Blend of Plant Protein and Additional Ingredients on Resistance Training Adaptations". This study seeks to compare the observed changes in resistance training adaptations (strength, performance, body composition, recovery, and lactate responses) after supplementation of isocaloric and isonitrogenous amounts of a novel plant protein formulation against changes observed in a pea/rice pl...
What is the current status of trial NCT06908811?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2022-08-19. Estimated completion is 2025-01-17.
What interventions are being tested in trial NCT06908811?
The interventions under investigation include: Whey Protein (DIETARY_SUPPLEMENT), Novel Plant Protein Blend (DIETARY_SUPPLEMENT), Pea/Rice Protein Blend (DIETARY_SUPPLEMENT), Carbohydrate Placebo (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06908811?
This trial is sponsored by Lindenwood University, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06908811's enrollment target sits among peer trials
60 1164th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI